<?xml version="1.0" encoding="UTF-8"?>
<p>It is ethically unacceptable to expose clinical trial participants to risk if the study is not designed to provide valid results.[
 <xref rid="ref3" ref-type="bibr">3</xref>] Hence, methodology – randomization, blinding, and placebo use – for a clinical should be rigorous to enhance the societal value and the scientific validity.[
 <xref rid="ref2" ref-type="bibr">2</xref>
 <xref rid="ref3" ref-type="bibr">3</xref>] However, insisting on randomization in clinical trials of severe epidemics would create a conflict between individual health and societal interests. Randomization would preclude the autonomy of patients in making a choice of therapy.[
 <xref rid="ref2" ref-type="bibr">2</xref>
 <xref rid="ref4" ref-type="bibr">4</xref>
 <xref rid="ref7" ref-type="bibr">7</xref>]
</p>
